Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Lilly Options Ghrelin-Based Diabetes Program from Alizé

Jan. 27, 2010

By Cormac Sheridan

FDA Refuses to Approve SkyePharma Asthma Drug

Jan. 27, 2010

Germany's Priaxon Getting up to $122M in Boehringer Cancer Deal

Jan. 27, 2010

By Catherine Hollingsworth

Comments from EU Health Chief Designate Has Industry on Edge

Jan. 20, 2010

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

Jan. 20, 2010

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

Jan. 20, 2010

By Cormac Sheridan

U.S. Scientific Inventory Shows Asia, EU Gaining in R&D Status

Jan. 20, 2010

40 UK Companies Will Share in £8.3M Stem Cell Program

Jan. 20, 2010

Rapid U.S. Biomedical Research Funding Is Dead: JAMA Report

Jan. 20, 2010

Other News To Note

Jan. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...